All Updates

All Updates

icon
Filter
Partnerships
Massive Bio collaborates with NeoGenomics to enhance oncology drug discovery
Precision Medicine
Mar 22, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Precision Medicine

Precision Medicine

Mar 22, 2023

Massive Bio collaborates with NeoGenomics to enhance oncology drug discovery

Partnerships

  • Bioinformatics platform Massive Bio has partnered with global oncology contract research service NeoGenomics to accelerate the development of cancer treatments.

  • NeoGenomics will use real-time identification to identify patients that qualify for clinical trials based on their biomarker status. Massive Bio will support NeoGenomics with obtaining patient consent and accelerating the process of further screening and possible enrollment. Through this collaboration, patients who meet the criteria for clinical trials can be identified, allowing patients and healthcare providers to make informed decisions about their potential treatment options.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.